Brian Mossop Brian Mossop

The continuing plight of the Sioux

Sad statistics, laid out in a provoking article from The Atlantic.

Despite sitting on a trust fund that's worth over $1 billion in equity from a "purchase" of the Black Hills that the tribe never agreed to, the Sioux are suffering from chronic disease and have what's sure to be one of the lowest ethnic life expectancies in the United States:

black-hills-480

Sad statistics, laid out in a provoking article from The Atlantic.

Despite sitting on a trust fund that's worth over $1 billion in equity from a "purchase" of the Black Hills that the tribe never agreed to, the Sioux are suffering from chronic disease and have what's sure to be one of the lowest ethnic life expectancies in the United States:

According to Oglala President John Yellow Bird Steele, almost half of Oglala Sioux over 40 have diabetes, and in the Western Hemisphere, few countries have shorter life expectancies (for men it is 48; for women, 52).

Photo via Flickr / cm195902

Brian Mossop is currently the Community Editor at Wired, where he works across the brand, both magazine and website, to build and maintain strong social communities. Brian received a BS in Electrical Engineering from Lafayette College, and a PhD in Biomedical Engineering from Duke University in 2006. His postdoctoral work was in neuroscience at UCSF and Genentech.

Brian has written about science for Wired, Scientific American, Slate, Scientific American MIND, and elsewhere. He primarily cover topics on neuroscience, development, behavior change, and health.

Contact Brian at brian.mossop@gmail.com, on Twitter (@bmossop), or visit his personal website.

Read More
Brian Mossop Brian Mossop

New Biomarkers for Diabetes

Obesity (determined by BMI) and blood glucose levels are by far the best predictors of whether a person will develop diabetes. Yet doctors are always on high alert for new biomarkers that may be more sensitive indicators of which patients will develop diabetes in the near future. The idea of using biomarkers to predict diabetes is not entirely new. Glycated hemoglobin (HbA1C) values are now routinely being monitored to screen for at-risk patients. However, a new study in PLoS One shows that several new biomarkers in the blood may further our understanding of exactly who’s at risk for diabetes, and increase our knowledge of the etiology of the disease.

Obesity (determined by BMI) and blood glucose levels are by far the best predictors of whether a person will develop diabetes. Yet doctors are always on high alert for new biomarkers that may be more sensitive indicators of which patients will develop diabetes in the near future. The idea of using biomarkers to predict diabetes is not entirely new. Glycated hemoglobin (HbA1C) values are now routinely being monitored to screen for at-risk patients. However, a new study in PLoS One shows that several new biomarkers in the blood may further our understanding of exactly who’s at risk for diabetes, and increase our knowledge of the etiology of the disease.

Veikko Salomaa and colleagues from the Department of Chronic Disease Prevention at the National Institute for Health and Welfare in Helsinki, Finland, tested nearly 13,000 people and found almost 600 cases of diabetes during routine follow-up exams.

According to the study, low levels of adiponectin, and high levels of apoB, C-reactive protein (CRP), and insulin, increase the chance that a woman will develop diabetes. When these factors were measured, proper diabetes prediction increased by 14% compared to when doctors only use classic risk factors, such as BMI and blood glucose levels, to predict disease.

The biomarkers that best predicted diabetes in men were low adiponectin, and high levels of CRP, interleukin-1 receptor antagonist, and ferritin. Accounting for these biomarkers led to a 25% increase in correct diabetes detection in the cohort.

read the study here.

Read More
Brian Mossop Brian Mossop

Can High Blood Glucose Levels Cause Cancer?

Diets high in simple sugars and refined carbs cause metabolic disorders and Type II diabetes in millions of Americans. But to make matters worse, new evidence suggests that high sugar diets may be even more dangerous than we initially thought. Having too much excess sugar in the bloodstream is never a good thing, and can lead to medical complications such as kidney failure, cardiovascular disease, and eye problems. But could high blood sugar also cause cancer? A Swedish research team addressed this question by tracking over 500,000 patients for 10-25 yeas, and published their results in the December issue of PLoS Medicine.

Diets high in simple sugars and refined carbs cause metabolic disorders and Type II diabetes in millions of Americans. But to make matters worse, new evidence suggests that high sugar diets may be even more dangerous than we initially thought. Having too much excess sugar in the bloodstream is never a good thing, and can lead to medical complications such as kidney failure, cardiovascular disease, and eye problems. But could high blood sugar also cause cancer? A Swedish research team addressed this question by tracking over 500,000 patients for 10-25 yeas, and published their results in the December issue of PLoS Medicine.

Similar to the findings of a study conducted in Korea in 2005, the European research team discovered that having elevated blood glucose levels increased the risk of developing certain types cancer later in life, such as pancreatic tumors in women and liver tumors in men. Not only had more cases of cancer occurred when people had high blood sugar, but the chance of survival also plummeted, especially when the person had cervical, espohageal, or colorectal cancers.

The authors present two theories on why elevated blood glucose levels could cause cancer: 1.) high sugar diets may cause an overproduction of insulin or insulin-like growth factor 1 (IGF-1), both of which promote rapid growth of new cells, the catalyzing step to tumor formation. 2.) More glucose in the blood stream could simply be adding fuel to the fire, feeding rogue tumor cells that need lots of energy to run.

Because the studies lacked certain controls, we can't say for sure whether elevated blood glucose levels cause certain tumors to form. For example, the people with high blood glucose levels may have been sedentary, and so the lack of exercise may be what's actually increasing the chances of developing cancer. Regardless, this study gives yet another example of unhealthy lifestyles contributing to comorbidity, a topic discussed at length by Thomas in The Decision Tree book.

Read More